Compatible with Asymptomatic and Symptomatic Pooling
The PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay can be used for sample pooling with oropharyngeal swab, nasopharyngeal swab and saliva samples of either asymptomatic and symptomatic individuals. This test is also for the qualitative detection of nucleic acid from the SARS-CoV-2 virus in pooled specimens containing up to 5 individual specimens (nasopharyngeal swabs and saliva) on chemagic™ 360 instrument, where each specimen is collected under observation or by a healthcare provider using individual vials containing transport media.
Pooling is desirable because it allows labs to reduce costs and increase throughput, but it requires a sensitive assay. The PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay builds on the most sensitive commercially available SARS-CoV-2 test kit with the lowest limitation of detection in the market, according to the FDA’s reference panel comparative data*. Automation solutions are available delivering plug-and-play pooling prior to viral RNA isolation.
The complete PerkinElmer® SARS-CoV-2 Real-time RT-PCR workflow delivers the sensitivity needed for:
- back to work screening
- back to school screening
* FDA Reference Panel Comparative Data. Oct. 2, 2020.